reasons Enrolled=1876; took open label treatment=1854 phase=1100
fulfilled=222 - Lost follow up=176 - Severe nonadherence=27
response=18 - Study terminated by sponsor=5 - Death=1 - Other=29 Completed open label phase=787
treatment=776 Placebo=385 Quetiapine XR=391 Excluded from ITT=1b Excluded from ITT=4b depressed event=127
continue=47 - Lost follow up=21 - AE=16 - Severe nonadherence protocol=2
response=1 - Incorrect randomization=1 - Death=1 - Study terminated by sponsor=146 - Other=16
AE=27 - Not willing continue=24 - Lost follow up=17 - Severe nonadherence protocol=7
fulfilled=4 - Incorrect randomization=3 - Study terminated by sponsor=202 - Other=39 randomized phase=5 randomized phase=10 aThis number includes 11
n=387 Hazard ratio=.34; 95% confidence interval .25.46; p<.001 48 52

THE FEELINGS CLUB: RANDOMIZED CONTROLLED EVALUATION OF SCHOOL-BASED CBT FOR ANXIOUS OR DEPRESSIVE SYMPTOMS

VIRTUAL REALITY EXPOSURE THERAPY IN ANXIETY DISORDERS: A SYSTEMATIC REVIEW OF PROCESS-AND-OUTCOME STUDIES

CONCEPTUAL BACKGROUND, DEVELOPMENT, AND PRELIMINARY DATA FROM THE UNIFIED PROTOCOL FOR TRANSDIAGNOSTIC TREATMENT OF EMOTIONAL DISORDERS

VALIDITY OF A SIMPLER DEFINITION OF MAJOR DEPRESSIVE DISORDER

POTENTIAL USE OF INTERNET-BASED SCREENING FOR ANXIETY DISORDERS: A PILOT STUDY

AUTONOMIC CARDIAC CONTROL IN DEPRESSED ADOLESCENTS

clinical characteristics of 5 post hoc analysis

POSTTRAUMATIC STRESS AND SOCIAL ANXIETY: THE INTERACTION OF TRAUMATIC EVENTS AND INTERPERSONAL FEARS

THE PSYCHOLOGICAL IMPACT OF TERRORIST ATTACKS: EXAMINING A DOSE-RESPONSE RELATIONSHIP BETWEEN EXPOSURE TO 9/11 AND AXIS I MENTAL DISORDERS

NESARC-2; N=34653, ages 201 collectedbetween2004

DOES PTSD MODERATE THE RELATIONSHIP BETWEEN SOCIAL SUPPORT AND SUICIDE RISK IN IRAQ AND AFGHANISTAN WAR VETERANS SEEKING MENTAL HEALTH TREATMENT?

university of washington internal review

GENDER DIFFERENCES IN DEPRESSION AND PTSD SYMPTOMS FOLLOWING COMBAT EXPOSURE

RELATIONSHIP BETWEEN RESPIRATORY, ENDOCRINE, AND COGNITIVE-EMOTIONAL FACTORS IN RESPONSE TO A PHARMACOLOGICAL PANICOGEN